Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06301139
Other study ID # P17-004
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date February 1, 2024

Study information

Verified date March 2024
Source Ausnutria Hyproca B.V.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the investigators aim to assess that infants with mild symptoms have significantly less (severe) symptoms after 14 days goat milk-based formula use compared to infants using cow's milk-based formula supplemented with probiotic drops.


Description:

Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this randomized controlled pilot study, the effect on comfort during usage of goat-milk based infant formula is studied. Twenty formula fed infants (aged between 6 weeks and 3 months) who experience mild discomfort will receive goat milk-based infant formula (GMF) or cow's mik based infant formula supplemented with probiotics lactobacillus reuteri drops (CMFp). The infants will be assessed by a local paediatricians using the Cow's Milk-related Symptom Score (CoMiSS). This is a fast, non-invasive and easy-to-use and validated questionnaire to assess infant's reaction to proteins found in cow's milk. The higher the score, the more sensitive the child is to cow's milk proteins, the maximum score is 33 points. Infants with a CoMiSS Score between 6 and 12 will be enrolled in this study. It is expected that infants will have a better response to GMF, which will result in a decrease of the CoMiSS Score after a 2 weeks intervention.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date February 1, 2024
Est. primary completion date April 1, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Weeks to 3 Months
Eligibility Inclusion Criteria: - Healthy full-term infant with birth weight =2,500 to =4,500 g - Infant aged between 4 weeks and 3 months at enrolment - CoMiSS value at baseline between 6 and 12 - Infant is exclusively bottle fed with cow's milk based infant formula at baseline Exclusion Criteria: - Breastfed infants - Congenital illness or malformation that may affect infant feeding or normal growth - Gastrointestinal disorders - Confirmed cow or goat milk protein allergy or lactose intolerance - Supplemental feeding - Readmission to hospital for longer than 3 days for another reason than hyperbilirubinemia prior to enrolment - Infant participating in another clinical study

Study Design


Intervention

Dietary Supplement:
Goat milk-based infant formula
Infant formula based on goat milk for 4 weeks at volume depending on the infant
Cow's milk-based infant formula with probiotic drops
Infant formula based on cow's milk with probiotic Lactobacillus reuteri drops for 4 weeks at volume depending on the infant

Locations

Country Name City State
Spain HM hospitales Madrid

Sponsors (2)

Lead Sponsor Collaborator
Ausnutria Hyproca B.V. HM hospitales

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cow's Milk-related Symptoms Difference in Cow's Milk related Symptom Score (CoMiSS: score ranges from 0 to 33 with higher scores indicating more symptoms) at baseline and after 14 days of intervention. 0-2 weeks
Secondary Cow's Milk-related Symptoms Difference in Cow's Milk-related Symptoms Score (CoMiSS: score ranges from 0 to 33 with higher scores indicating more symptoms) at baseline and after 28 days of intervention. 0-4 weeks
Secondary Parental stress Difference in parental stress measured by Parental Stress Index-Short Form (PSI-SF: score ranges from 15% to 100% with higher scores indicating more stress) at baseline, after 5 days, after 9 days and after 28 days of intervention. 0-4 weeks
Secondary Parental quality of life Difference in parental quality of life measured by World Health Organization Quality Of Life questionnaire - short version (WHOQOL-BREF: score ranges from 0 to 100 with higher scores indicating better quality of life ) at baseline, after 5 days, after 9 days and after 28 days of intervention. 0-4 weeks
Secondary Weight Difference in weight (grams) at baseline, after 14 days and after 28 days of intervention. 0-4 weeks
Secondary Length Difference in length (cm) at baseline, after 14 days and after 28 days of intervention. 0-4 weeks
Secondary Weight-for-age Difference in weight-for-age z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention. 0-4 weeks
Secondary Length-for-age Difference in length-for-age z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention. 0-4 weeks
Secondary Weight-for-length Difference in weight-for-length z-scores calculated using the World Health Organization Child Growth Standards at baseline, after 14 days and after 28 days of intervention. 0-4 weeks
See also
  Status Clinical Trial Phase
Terminated NCT02541357 - Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery N/A
Active, not recruiting NCT02358122 - Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh N/A
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Enrolling by invitation NCT00943345 - Validation of New Tests for Gastrointestinal (GI) Permeability Phase 0
Completed NCT00612404 - Symptoms and Endoscopic Results in Consideration of Pretreatment N/A
Completed NCT01127711 - Cohort of Swedish Men N/A
Recruiting NCT05712525 - Gut Recovery In Patients Following Surgery
Recruiting NCT06094153 - Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function N/A
Recruiting NCT05322486 - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed NCT02486146 - GI Biorepository of Tissue and Bodily Fluids N/A
Completed NCT01816607 - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed NCT00247715 - Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study) N/A
Completed NCT00035334 - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis Phase 2/Phase 3
Recruiting NCT06286865 - Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial N/A
Active, not recruiting NCT01037049 - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks Phase 2
Completed NCT03725813 - Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit N/A
Recruiting NCT05640401 - Holographic Screens as a Replacement of Monitors During GI Endoscopies N/A
Completed NCT02865564 - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics N/A
Completed NCT02651857 - Exploratory Study of Upper and Lower Endoscopic Fuse System N/A
Active, not recruiting NCT01984034 - Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines N/A